Missing/wrong data?
Log in to edit
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.
scientific article published on 17 February 2015
Author/s
author: Miguel Martin, Serafin Morales, Jose A Garcia-Saenz, Eva Carrasco
Work details
Publication date
February 17, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.